chr22-26666705-G-A

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BA1

The ENST00000613780.4(MIAT):​n.1467G>A variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.134 in 398,554 control chromosomes in the GnomAD database, including 3,795 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (no stars).

Frequency

Genomes: 𝑓 0.14 ( 1665 hom., cov: 32)
Exomes 𝑓: 0.13 ( 2130 hom. )

Consequence

MIAT
ENST00000613780.4 non_coding_transcript_exon

Scores

2

Clinical Significance

Benign no assertion criteria provided B:1

Conservation

PhyloP100: 0.0440

Publications

22 publications found
Variant links:
Genes affected
MIAT (HGNC:33425): (myocardial infarction associated transcript) This gene encodes a spliced long non-coding RNA that may constitute a component of the nuclear matrix. Altered expression of this locus has been reported to be associated with a susceptibility to myocardial infarction. It has also been proposed that pathways involving this transcript may contribute to the pathophysiology of schizophrenia. A similar gene in mouse has been associated with retinal cell fate determination. Alternatively spliced transcript variants have been identified. [provided by RefSeq, Dec 2014]
MIATNB (HGNC:50731): (MIAT neighbor)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.83).
BP6
Variant 22-26666705-G-A is Benign according to our data. Variant chr22-26666705-G-A is described in ClinVar as Benign. ClinVar VariationId is 2691796.Status of the report is no_assertion_criteria_provided, 0 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.18 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MIATNR_003491.4 linkn.1399G>A non_coding_transcript_exon_variant Exon 3 of 5
MIATNR_033319.3 linkn.1399G>A non_coding_transcript_exon_variant Exon 3 of 4
MIATNR_033320.3 linkn.1325G>A non_coding_transcript_exon_variant Exon 3 of 5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MIATENST00000613780.4 linkn.1467G>A non_coding_transcript_exon_variant Exon 3 of 5 1
MIATENST00000616213.4 linkn.1393G>A non_coding_transcript_exon_variant Exon 3 of 4 1
MIATENST00000616469.4 linkn.1519G>A non_coding_transcript_exon_variant Exon 3 of 4 1

Frequencies

GnomAD3 genomes
AF:
0.143
AC:
21723
AN:
152076
Hom.:
1661
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.184
Gnomad AMI
AF:
0.261
Gnomad AMR
AF:
0.0951
Gnomad ASJ
AF:
0.132
Gnomad EAS
AF:
0.103
Gnomad SAS
AF:
0.0820
Gnomad FIN
AF:
0.158
Gnomad MID
AF:
0.133
Gnomad NFE
AF:
0.133
Gnomad OTH
AF:
0.125
GnomAD4 exome
AF:
0.129
AC:
31742
AN:
246360
Hom.:
2130
Cov.:
0
AF XY:
0.130
AC XY:
16198
AN XY:
124840
show subpopulations
African (AFR)
AF:
0.179
AC:
1284
AN:
7182
American (AMR)
AF:
0.0817
AC:
607
AN:
7434
Ashkenazi Jewish (ASJ)
AF:
0.120
AC:
1109
AN:
9242
East Asian (EAS)
AF:
0.0707
AC:
1620
AN:
22898
South Asian (SAS)
AF:
0.0818
AC:
248
AN:
3032
European-Finnish (FIN)
AF:
0.157
AC:
3262
AN:
20824
Middle Eastern (MID)
AF:
0.138
AC:
179
AN:
1294
European-Non Finnish (NFE)
AF:
0.134
AC:
21194
AN:
158078
Other (OTH)
AF:
0.137
AC:
2239
AN:
16376
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
2074
4148
6222
8296
10370
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
106
212
318
424
530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.143
AC:
21744
AN:
152194
Hom.:
1665
Cov.:
32
AF XY:
0.143
AC XY:
10650
AN XY:
74412
show subpopulations
African (AFR)
AF:
0.184
AC:
7619
AN:
41498
American (AMR)
AF:
0.0948
AC:
1450
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.132
AC:
460
AN:
3472
East Asian (EAS)
AF:
0.102
AC:
531
AN:
5184
South Asian (SAS)
AF:
0.0827
AC:
399
AN:
4826
European-Finnish (FIN)
AF:
0.158
AC:
1672
AN:
10596
Middle Eastern (MID)
AF:
0.146
AC:
43
AN:
294
European-Non Finnish (NFE)
AF:
0.133
AC:
9070
AN:
68006
Other (OTH)
AF:
0.124
AC:
262
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
912
1824
2736
3648
4560
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
244
488
732
976
1220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.134
Hom.:
941
Bravo
AF:
0.141
Asia WGS
AF:
0.0880
AC:
305
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

MIAT-related disorder Benign:1
Jan 28, 2020
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.83
CADD
Benign
1.8
DANN
Benign
0.68
PhyloP100
0.044

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2301523; hg19: chr22-27062669; API